Nevertheless, figure 5D, E demonstrate marked upregulation of both CD68 and CD163 staining in the baseline biopsy of a poorly responding tumor when compared with the baseline biopsy of the tumor showing a good radiotherapy response. The gene discussed is CD163; the disease is neoplasm.